NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, reminds purchasers of Nobilis Health Corp. (NYSE:HLTH) securities from April 2, 2015 through October 8, 2015 of the important December 21, 2015 lead plaintiff deadline in the class action. The lawsuit seeks to recover investors’ losses under the federal securities laws.
To join the Nobilis class action, visit the firm’s website at http://www.rosenlegal.com/cases-744.html, or contact Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or via email at pkim@rosenlegal.com or kchan@rosenlegal.com for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY CHOOSE TO DO NOTHING AT THIS POINT AND REMAIN AN ABSENT CLASS MEMBER.
According to the lawsuit, Defendants made false and/or misleading statements and/or failed to disclose that: (1) Nobilis claimed success rates for its AccuraScope procedure lacked recognition from any university, medical body, or insurance company; (2) Nobilis overstated its 2014 revenues by as much as $36 million; (3) consequently, Nobilis misrepresented its 2014 revenue growth rate as 161%, when it was actually only 44%; and (4) as a result of the foregoing, Nobilis’s public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than December 21, 2015. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to the firm’s website at http://www.rosenlegal.com/cases-744.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll-free at 866-767-3653 or via e-mail at pkim@rosenlegal.com or kchan@rosenlegal.com.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
